K-numberK250138
Device nameSmall Volume 0.2mL Syringe
ApplicantProsum Medical Limited
Product codeQNQ
Device classClass II
Decision dateApr 2, 2025
DecisionSubstantially Equivalent
Regulation880.5860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Small Volume 0.2mL Syringe is a manual, single-use piston syringe intended for medical injection and withdrawal of fluids from the body. It features a polypropylene barrel, ABS plunger, TPE stopper, and Luer-lock connection to hypodermic needles. The device includes optional protective components (Luer cap and plunger shield) and comes in six models, three with enhanced dosing technology markings.

Technological characteristics

The device is a 0.2 mL syringe with Luer-lock connection, lower dead space (≤0.0058 mL vs. predicate's ≤0.023 mL), uses different materials (ABS plunger, TPE stopper vs. predicate's PP and rubber), includes optional protective caps and shields, and achieves lower total volume than the 1 mL predicate while maintaining the same sterilization method (EO gas, SAL 10^-6) and 3-year shelf-life.

Test standards cited

ISO 7886-1 (syringe performance), ISO 80369-7 and ISO 80369-20 (Luer connector), ISO 10993-1 (biocompatibility: cytotoxicity, irritation, sensitization, acute systemic toxicity, hemocompatibility, pyrogenicity), ISO 11135 (sterilization validation), ASTM F1980 (accelerated aging), ASTM D4169-22 (shipping simulation), USP <788> (particulate matter), USP <85> (bacterial endotoxins), and ASTM F88/F88-15 and ASTM F1929-15 (seal strength and leak testing).

Substantial equivalence argument

The device differs from its predicate (K210443) in syringe volume (0.2 mL vs. 1 mL), dead space specification (lower volume achieved), component materials (ABS and TPE vs. PP and rubber), and inclusion of optional protective components. These differences do not raise new safety or effectiveness questions because: (1) the smaller volume is accompanied by proportionally lower dead space, both meeting ISO 7886-1 performance requirements; (2) biocompatibility is demonstrated per ISO 10993-1 for all materials; (3) the protective caps and shields are discarded before use and do not affect mechanism of action; and (4) sterilization, shelf-life, and intended use remain identical.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →